Chongqing Boteng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") held the Tenth Temporary Meeting of the Sixth Board of Directors on June 5, 2026 (Friday) via teleconference. The meeting notice was sent to all directors via email on June 3, 2026. A total of 8 directors were required to participate in the vote, and all 8 directors participated. The meeting was chaired by Mr. Ju Nianfeng, and some senior management personnel attended the meeting. The meeting was conducted in accordance with the provisions of the Company Law and the Articles of Association, and the resolutions made were legal and valid.
I. Meeting Review
The meeting, ensuring that all directors had the opportunity to express their opinions, voted and passed the following proposals:
(1) Proposal to Terminate Investment in the Slovenian R&D Production Base
The proposal to terminate the investment in the construction of the Slovenian R&D production base was approved. For specific details, please refer to the announcement titled "Announcement on the Progress of External Investment and Termination of the Construction of the Slovenian R&D Production Base" published on the same day on the Giant Tide Information Network (www.cninfo.com.cn) (Announcement No.: 2026-037).
Voting results: 8 votes in favor, 0 votes against, 0 abstentions.